Immunomodulatory Effects of Vitamin D3 on the Expression of IL-6, IFN-ã and T-BET in Inflammatory Bowel Diseases

Immunomodulatory Effects of Vitamin D3 on the Expression of IL-6, IFN-ã and T-BET in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) is an immune mediated dysfunction in a genetically susceptible host. Crohn's diseases (CD) and ulcerative colitis (UC) are serotypes of IBD. They are important cause of gastrointestinal diseases. Patients with IBD are predisposed to colon cancer. It is therefor...

Full description

Saved in:

Bibliographic Details
Main Author:	1,2 1 Alhassan H.M. * and Yaraghi A.S.
Format:	Article
Language:	English
Published:	Hammer Head Production Limited 2024-03-01
Series:	Sokoto Journal of Medical Laboratory Science
Subjects:	1,25(o0h)2d3, ibd, ulcerative colitis, crohn's disease, immunomodulation
Online Access:	https://sokjmls.com.ng/index.php/SJMLS/article/view/462
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of diet on the inflammatory bowel disease course – a literature review
by: Agnieszka Nowotarska, et al.
Published: (2024-11-01)

Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
by: A. I. Akinshina, et al.
Published: (2019-05-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

The role of GLP-1 receptor agonists in IBD-related surgery and IBD-related complications of inflammatory bowel disease among patients with metabolic comorbidities: a systematic review and meta-analysis
by: Mengqi Yang, et al.
Published: (2025-08-01)

Prevalence of Vitamin D Deficiency in Patients with Inflammatory Bowel Disease
by: Paula de Souza Pereira, et al.
Published: (2025-03-01)

Crime detective: towards the first description of inflammatory bowel diseases
by: V. V. Balutsky, et al.
Published: (2024-08-01)

The First Saint Petersburg Regional Inflammatory Bowel Diseases Registry on the Basis of the Regional Health Information System: Principles of Functioning, Testing Results, Plan of Development
by: Yu. P. Uspenskiy, et al.
Published: (2023-11-01)

Metabolic Disorders and Inflammatory Bowel Diseases
by: Hye Kyung Hyun, et al.
Published: (2025-05-01)

Helminths in alternative therapeutics of inflammatory bowel disease
by: Himani Pandey, et al.
Published: (2025-01-01)

Evaluation of the association between periodontitis and inflammatory bowel disease: A systematic review and Meta-analysis
by: Narges Naghsh, et al.
Published: (2025-08-01)

The prevalence of myasthenia gravis is increased in inflammatory bowel disease
by: Antônio Miguel Furtado Leitão, et al.
Published: (2025-04-01)

THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES
by: Yasin Kutlu, et al.
Published: (2021-07-01)

Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease
by: Claudia Cabrera, et al.
Published: (2025-08-01)

INFLAMMATORY BOWEL DISEASE: CYTOCHEMICAL ACTIVITY OF INTRACELLULAR ENZYMES OF PERIPHERAL BLOOD NEUTROPHILS AND MONOCYTES IN DIAGNOSIS
by: V. A. ЕMELYANOVA, et al.
Published: (2017-09-01)

Influence of risk factors on bone density in inflammatory bowel diseases
by: Dobrovoljski Daniela, et al.
Published: (2025-01-01)

Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2015-05-01)

Health Related Quality of Life and Associated Factors of Inflammatory Bowel Disease Outpatient Unit in Dr. Cipto Mangunkusumo Hospital
by: Muhammad Fikri Afistianto, et al.
Published: (2025-08-01)

Varying patterns of risk factors for inflammatory bowel disease in the East and the West: insights from the global burden of disease study 2021
by: Yiming Zhang, et al.
Published: (2025-07-01)

Characteristics of the course of inflammatory bowel diseases among the residents of the Kabardino-Balkarian Republic
by: R. Kh. Kazhaeva, et al.
Published: (2024-04-01)

Adherence to treatment in patients with inflammatory bowel disease
by: K. A. Andreev, et al.
Published: (2021-10-01)

Hydrogen sulfide preserves intestinal barrier repair function through sulfhydration of RPS20 in experimental colitis
by: Xuan He, et al.
Published: (2025-05-01)

Evaluation of microbiome composition combined with serum untargeted metabolomic profiling in newly diagnosed children with inflammatory bowel disease
by: Katarzyna Zdanowicz, et al.
Published: (2024-07-01)

Structured exercise in patients with inflammatory bowel disease: a literature review
by: Magdalena Achtenberg, et al.
Published: (2025-03-01)

Trends in precision diagnosis and monitoring of inflammatory bowel diseases: the potential of proteomic and metabolomic biomarkers
by: S. V. Lyamina, et al.
Published: (2025-07-01)

Indigo naturalis for inflammatory bowel disease: evidence from animal studies and molecular mechanisms
by: Jie Hu, et al.
Published: (2025-07-01)

The Possibilities of Assessing the Quality of Life in Inflammatory Bowel Diseases
by: Anna L. Arakelyan, et al.
Published: (2025-07-01)

Some aspects of treating inflammatory intestinal diseases
by: E. Yu. Plotnikova, et al.
Published: (2021-06-01)

Oncological standards in the treatment of diffuse inflammatory diseases of the colon
by: O. I. Poyda, et al.
Published: (2023-12-01)

Store‐operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease
by: Marilena Letizia, et al.
Published: (2022-08-01)

Anti‐Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review
by: Kiarash Ghazvini, et al.
Published: (2025-07-01)

Advance on establishment of pathological model of ulcerative colitis
by: Lan Yang, et al.
Published: (2025-08-01)

Janus Kinase Inhibitors in the Treatment of Crohn’s Disease and Ulcerative Colitis: A Review
by: Olimpia Wiciun, et al.
Published: (2025-05-01)

Perinuclear antineutrophilic cytoplasmatic antibodies at patients with ulcerative colitis and Crohn’s disease
by: Ye. A. Konovich, et al.
Published: (2009-10-01)

Nutrition in Inflammatory Bowel Disease: Strategies to Improve Prognosis and New Therapeutic Approaches
by: Nallely Bueno-Hernández, et al.
Published: (2025-05-01)

Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
by: Ying-Hsiang Wang, et al.
Published: (2025-01-01)

Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study
by: Marouf Alhalabi, et al.
Published: (2025-05-01)

Diagnostic Algorithm for Joint Pain in Patients with Inflammatory Bowel Disorders
by: A. I. Dolgushina, et al.
Published: (2022-01-01)

Autophagy in inflammatory bowel disease: immunization, etiology, and therapeutic potential
by: Zhong-Xing Miao, et al.
Published: (2025-08-01)

Persistence of biologic therapy in patients with inflammatory bowel diseases in the Chelyabinsk region
by: Anastasia I. Dolgushina, et al.
Published: (2025-01-01)

Human gut commensal Alistipes timonensis modulates the host lipidome and delivers anti-inflammatory outer membrane vesicles to suppress colitis in an Il10-deficient mouse model
by: Ethan A. Older, et al.
Published: (2025-12-01)